Showing results (31-40 of 144) with videos related to
Sort By:
Pageof 15
Health Affairs (Project Hope)|May 16, 2009
What does it cost physician practices to interact with health insurance plans?Lawrence P Casalino, Sean Nicholson, David N Gans, et al.JCO Global Oncology|July 7, 2020
ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study ProtocolAtara I Ntekim, Abiola Ibraheem, Adenike A Sofoluwe, et al.American Journal of Clinical Oncology|April 17, 2010
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinomaElizabeth K Chung, Edwin M Posadas, Kristen Kasza, et al.Blood Cancer Journal|October 7, 2024
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP)Benjamin A Derman, Ajay Major, Jennifer Cooperrider, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumorsM Eileen Dolan, Mitchell Posner, Theodore Karrison, et al.Human Molecular Genetics|October 10, 2009
Impaired replication dynamics at the FRA3B common fragile siteAparna Palakodeti, Isabelle Lucas, Yanwen Jiang, et al.Blood|January 2, 2014
Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in miceAngela Stoddart, Anthony A Fernald, Jianghong Wang, et al.Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|December 21, 2011
MET and phosphorylated MET as potential biomarkers in lung cancerMaria Tretiakova, April K S Salama, Theodore Karrison, et al.The American Journal of Chinese Medicine|June 29, 2007
Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trialSheila M Wicks, Robin Tong, Chong-Zhi Wang, et al.Human Molecular Genetics|September 1, 2009
Common fragile sites are characterized by histone hypoacetylationYanwen Jiang, Isabelle Lucas, David J Young, et al.Pageof 15